CXCL12 and type 1 diabetes mellitus: Our findings demonstrate that T1DM downregulates the expression of CXCL12, which can be effectively reversed by NAC treatment, consistent with transcriptomic analysis (Figure 6A,B) and mRNA levels (Figure 6C).